Advantage Trust CO Bristol Myers Squibb CO Transaction History
Advantage Trust CO
- $139 Billion
- Q2 2024
A detailed history of Advantage Trust CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Advantage Trust CO holds 2,475 shares of BMY stock, worth $138,030. This represents 0.07% of its overall portfolio holdings.
Number of Shares
2,475
Previous 2,502
1.08%
Holding current value
$138,030
Previous $136 Million
24.24%
% of portfolio
0.07%
Previous 0.1%
Shares
2 transactions
Others Institutions Holding BMY
# of Institutions
2,444Shares Held
1.51BCall Options Held
29.7MPut Options Held
32.1M-
Vanguard Group Inc Valley Forge, PA187MShares$10.4 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.85 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$5.1 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$4.16 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.29 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $119B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...